Advertisement
UK markets close in 1 hour 37 minutes
  • FTSE 100

    7,966.10
    +34.12 (+0.43%)
     
  • FTSE 250

    19,892.35
    +81.69 (+0.41%)
     
  • AIM

    743.68
    +1.57 (+0.21%)
     
  • GBP/EUR

    1.1697
    +0.0028 (+0.24%)
     
  • GBP/USD

    1.2634
    -0.0004 (-0.03%)
     
  • Bitcoin GBP

    56,577.95
    +1,420.39 (+2.58%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,252.61
    +4.12 (+0.08%)
     
  • DOW

    39,761.68
    +1.60 (+0.00%)
     
  • CRUDE OIL

    82.41
    +1.06 (+1.30%)
     
  • GOLD FUTURES

    2,232.60
    +19.90 (+0.90%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • DAX

    18,497.32
    +20.23 (+0.11%)
     
  • CAC 40

    8,217.14
    +12.33 (+0.15%)
     

How Many Alliance Pharma plc (LON:APH) Shares Do Institutions Own?

Every investor in Alliance Pharma plc (LON:APH) should be aware of the most powerful shareholder groups. Institutions often own shares in more established companies, while it's not unusual to see insiders own a fair bit of smaller companies. Companies that used to be publicly owned tend to have lower insider ownership.

Alliance Pharma is a smaller company with a market capitalization of UK£557m, so it may still be flying under the radar of many institutional investors. Our analysis of the ownership of the company, below, shows that institutional investors have bought into the company. Let's delve deeper into each type of owner, to discover more about Alliance Pharma.

Check out our latest analysis for Alliance Pharma

ownership-breakdown
ownership-breakdown

What Does The Institutional Ownership Tell Us About Alliance Pharma?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

ADVERTISEMENT

We can see that Alliance Pharma does have institutional investors; and they hold a good portion of the company's stock. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Alliance Pharma, (below). Of course, keep in mind that there are other factors to consider, too.

earnings-and-revenue-growth
earnings-and-revenue-growth

Investors should note that institutions actually own more than half the company, so they can collectively wield significant power. Alliance Pharma is not owned by hedge funds. The company's largest shareholder is FMR LLC, with ownership of 9.9%. In comparison, the second and third largest shareholders hold about 8.8% and 6.7% of the stock.

We also observed that the top 9 shareholders account for more than half of the share register, with a few smaller shareholders to balance the interests of the larger ones to a certain extent.

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too.

Insider Ownership Of Alliance Pharma

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

Our information suggests that Alliance Pharma plc insiders own under 1% of the company. It seems the board members have no more than UK£4.3m worth of shares in the UK£557m company. I generally like to see a board more invested. However it might be worth checking if those insiders have been buying.

General Public Ownership

The general public, with a 11% stake in the company, will not easily be ignored. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

Next Steps:

It's always worth thinking about the different groups who own shares in a company. But to understand Alliance Pharma better, we need to consider many other factors. Take risks for example - Alliance Pharma has 4 warning signs we think you should be aware of.

But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.